BioHorizons uses science and innovation to create unique dental implant products with proven aesthetic results. In 2011, the company was on the verge of an initial public offering when macroeconomic events closed the public capital markets. In need of bridge financing to the next IPO window and facing a depressed private equity financing market the company had few attractive options. Deerfield already had a deep knowledge of the dental implant space and worked closely with management to further understand BioHorizons’ business model, market opportunity and capital structure.